Search research articles
Contact Us
Filters
Showing results (111-120 of 179) with videos related to
Page
of 18
Sort By:
Diabetes Research and Clinical Practice
|
June 9, 2012
Effects of blood pressure lowering on cardiovascular outcomes in different cardiovascular risk groups among participants with type 2 diabetes
Susan van Dieren, Andre P Kengne, John Chalmers, et al.
BMJ Open Diabetes Research & Care
|
May 6, 2025
Relationship between time-varying achieved HbA<sub>1c</sub> and risk of coronary artery disease events among common haptoglobin phenotype groups with type 2 diabetes: the ADVANCE study
Leah E Cahill, Rachel A Warren, Samantha K Lavallée, et al.
BMJ Global Health
|
December 2, 2024
May Measurement Month 2022: results from the global blood pressure screening campaign
Thomas Beaney, Gabriele Keziah Kerr, Gaia Kiru, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology
|
September 5, 2020
May Measurement Month 2018: blood pressure screening results in Cameroon
Anastase Dzudie, Epie Njume, Jerome Boombhi, et al.
Diabetes Care
|
May 26, 2021
The Impact of Frailty on the Effectiveness and Safety of Intensive Glucose Control and Blood Pressure-Lowering Therapy for People With Type 2 Diabetes: Results From the ADVANCE Trial
Tu N Nguyen, Katie Harris, Mark Woodward, et al.
Plos One
|
February 8, 2013
Effects of the endpoint adjudication process on the results of a randomised controlled trial: the ADVANCE trial
Jun Hata, Hisatomi Arima, Sophia Zoungas, et al.
Diabetes Care
|
March 14, 2024
Haptoglobin Phenotype and Intensive Glycemic Control for Coronary Artery Disease Risk Reduction in People With Type 2 Diabetes: The ADVANCE Study
Leah E Cahill, Rachel A Warren, Allie S Carew, et al.
Diabetes Care
|
March 24, 2016
Long-term Benefits of Intensive Glucose Control for Preventing End-Stage Kidney Disease: ADVANCE-ON
Muh Geot Wong, Vlado Perkovic, John Chalmers, et al.
Journal of Hypertension
|
May 21, 2010
Efficacy and safety of routine blood pressure lowering in older patients with diabetes: results from the ADVANCE trial
Toshiharu Ninomiya, Sophia Zoungas, Bruce Neal, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology
|
September 5, 2020
May Measurement Month 2018: an analysis of blood pressure screening results from Ghana
Betty Twumasi-Ankrah, Gustavus A Myers-Hansen, Yaw Adu-Boakye, et al.
Page
of 18
Search research articles
Search
Showing results (111-120 of 179) with videos related to
Sort By:
Page
of 18
Diabetes Research and Clinical Practice
|
June 9, 2012
Effects of blood pressure lowering on cardiovascular outcomes in different cardiovascular risk groups among participants with type 2 diabetes
Susan van Dieren, Andre P Kengne, John Chalmers, et al.
BMJ Open Diabetes Research & Care
|
May 6, 2025
Relationship between time-varying achieved HbA<sub>1c</sub> and risk of coronary artery disease events among common haptoglobin phenotype groups with type 2 diabetes: the ADVANCE study
Leah E Cahill, Rachel A Warren, Samantha K Lavallée, et al.
BMJ Global Health
|
December 2, 2024
May Measurement Month 2022: results from the global blood pressure screening campaign
Thomas Beaney, Gabriele Keziah Kerr, Gaia Kiru, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology
|
September 5, 2020
May Measurement Month 2018: blood pressure screening results in Cameroon
Anastase Dzudie, Epie Njume, Jerome Boombhi, et al.
Diabetes Care
|
May 26, 2021
The Impact of Frailty on the Effectiveness and Safety of Intensive Glucose Control and Blood Pressure-Lowering Therapy for People With Type 2 Diabetes: Results From the ADVANCE Trial
Tu N Nguyen, Katie Harris, Mark Woodward, et al.
Plos One
|
February 8, 2013
Effects of the endpoint adjudication process on the results of a randomised controlled trial: the ADVANCE trial
Jun Hata, Hisatomi Arima, Sophia Zoungas, et al.
Diabetes Care
|
March 14, 2024
Haptoglobin Phenotype and Intensive Glycemic Control for Coronary Artery Disease Risk Reduction in People With Type 2 Diabetes: The ADVANCE Study
Leah E Cahill, Rachel A Warren, Allie S Carew, et al.
Diabetes Care
|
March 24, 2016
Long-term Benefits of Intensive Glucose Control for Preventing End-Stage Kidney Disease: ADVANCE-ON
Muh Geot Wong, Vlado Perkovic, John Chalmers, et al.
Journal of Hypertension
|
May 21, 2010
Efficacy and safety of routine blood pressure lowering in older patients with diabetes: results from the ADVANCE trial
Toshiharu Ninomiya, Sophia Zoungas, Bruce Neal, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology
|
September 5, 2020
May Measurement Month 2018: an analysis of blood pressure screening results from Ghana
Betty Twumasi-Ankrah, Gustavus A Myers-Hansen, Yaw Adu-Boakye, et al.
Page
of 18